Preventing asthma exacerbations is a cornerstone of maintaining respiratory health and reducing hospitalizations in patients with asthma. Exacerbations can be triggered by viral infections, allergens, air pollution, or poor medication adherence, and may manifest as worsening cough, wheezing, shortness of breath, or nighttime symptoms. Identifying individual triggers, assessing risk factors, and monitoring lung function through peak flow measurements or spirometry are critical for early intervention and prevention. Patients with severe or uncontrolled asthma are particularly susceptible, highlighting the importance of proactive management strategies.
Effective prevention combines pharmacologic and non-pharmacologic measures. Maintenance therapy with inhaled corticosteroids, long-acting bronchodilators, and, when appropriate, biologic agents targeting IgE or interleukins can reduce inflammation and minimize exacerbation frequency. Environmental control, including allergen avoidance, smoking cessation, and air quality monitoring, further reduces risk. Patient education on inhaler technique, adherence, early recognition of worsening symptoms, and individualized action plans empowers self-management. Regular follow-up with healthcare providers ensures therapy is optimized, triggers are addressed, and exacerbations are minimized. Through coordinated care and adherence to preventive strategies, patients can achieve improved symptom control and better long-term outcomes.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation